| 发明名称 |
S1P MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN |
| 摘要 |
The present invention relates to siponimod (BAF312) for use in the treatment of an autoimmune disease, wherein an immediate release dosage form is administered once daily to a patient as maintenance regimen and wherein the patient has experienced a specific titration regimen with siponimod beforehand. |
| 申请公布号 |
PH12016501965(A1) |
申请公布日期 |
2017.01.09 |
| 申请号 |
PH12016501965 |
申请日期 |
2016.10.04 |
| 申请人 |
NOVARTIS AG |
发明人 |
LEGANGNEUX, ERIC;WALLSTROEM, ERIK;BOUILLOT, PHILIPPE MICHAEL RENE;REYNAUD, EMERIC;DAHLKE, FRANK |
| 分类号 |
A61K31/397;A61K9/20 |
主分类号 |
A61K31/397 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
